February 23, 2022 Lab Top-10 M&A, Partnerships PAI Top-10

Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration

Agreement to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies CAMBRIDGE, Mass., & WALTHAM, Mass.–(BUSINESS WIRE)– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a 15-year strategic collaboration agreement... Read more

February 21, 2022 Licensing, IP, and Legal M&A, Partnerships Product Launch

European Society of Radiology and GE Healthcare renew their strategic partnership for ECR 2022

Vienna, Austria – February 21, 2022 – The European Society of Radiology (ESR) and GE Healthcare announce today the renewal of their partnership for the online European Congress of Radiology (ECR Overture) on March 2-6, 2022, and onsite ECR 2022 on July 13-17 in Vienna, Austria. The partnership includes a complete 2,000m² new area and... Read more

February 21, 2022 Microscopy Product Launch

Driving New Discoveries With Lattice Light Sheet Microscopy in an Advanced Core Imaging Facility

The Centre for Dynamic Imaging (CDI) at the Walter and Eliza Hall Institute of Medical Research (WEHI) in Parkville, Victoria (Australia) is both a core facility and a research lab for advanced microscopy helping scientists use advanced imaging technology and powerful computational resources to generate detailed and real-time views of biological systems. These new insights... Read more

February 18, 2022 Lab Top-10

Bruker Announces Quarterly Dividend

Q1 2022 dividend increases to $0.05 from $0.04 per share in Q1 2021 BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on March 18,... Read more

February 16, 2022 Clinical Research/Diagn.

KK Women’s and Children’s Hospital and PacBio Collaborate in Asia’s First Study of Unexplained Neurodevelopmental Disorders

SINGAPORE and MENLO PARK, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) — KK Women’s and Children’s Hospital (KKH) and PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a collaboration to leverage PacBio technology in understanding the genetic causes of neurodevelopmental disorders. As part of the Bringing Research Innovations for the... Read more

February 16, 2022 Bio/Pharma/CRO Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 Product Launch

PerkinElmer’s SIRION Biotech Teams with Centre for Genomic Regulation to Develop New Generation AAV Vectors for Type 1 and Type 2 Diabetes Gene Therapy

Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its SIRION Biotech business, a world leader in viral vector-based gene delivery technologies for gene and cell therapy and vaccine development, and the Centre for Genomic Regulation (CRG), an international... Read more

February 15, 2022 Liq. Handling & Robotics PAI Top-10 PR/Corporate

PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results

MENLO PARK, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2021. Updates since our last earnings release Achieved record fourth quarter revenues of $36.0 million reflecting growth of 33% compared to the prior year period and grew the Sequel II/IIe... Read more